The nation of Zimbabwe has rejected a major American healthcare agreement worth $367m (£272m) over five years because of the United States' insistence on confidential information.
This rejection came to light following a internal memorandum dated December was leaked, revealing that Head of State Emmerson Mnangagwa deemed the arrangement was "unbalanced".
A government spokesman later clarified that the US was requesting genetic material for scientific study and commercial gain while was not willing to share the resulting advantages from future medical innovations.
"We are forced to start the challenging and unfortunate task of scaling back our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the US had provided over $1.9bn in health funding to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has urged more talks to reach a deal suitable to all parties so the country's critical HIV programme can be sustained.
Wider Background
This development follows a similar situation in neighbouring Kenya, where a court suspended a related deal with the US following concerns were raised about the security of citizens' medical information.
Since resuming office recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
The agency had administered aid for the US government, but Trump stated its spending was "wasteful" and his government was pursuing direct bilateral agreements to enhance transparency and accountability.
As per reports, Sixteen African countries have to date agreed to these new health pacts, constituting more than $18.3bn in committed funds.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We believe this cooperation could have provided immense advantages for the people of Zimbabwe, especially the 1.2 million men, women and children currently on HIV treatment through US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unfair".
"Our nation was requested to share its biological resources and data for a long time, without any corresponding assurance of benefiting from any medical innovations – such as new medicines or tests – that could be developed from that provided information," his statement read.
"Effectively, our nation would supply the raw materials for scientific discovery without any assurance that the end products would be available to our people should a new disease outbreak emerge."
National Interest and Global Health
He also pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one health agreements were undermining frameworks previously established through the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing framework created to manage future global health emergencies.
"This system is designed to ensure that when a country contributes its data, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised exclusively by those with the resources to create them."
These objections over the US deal "are not meant as hostility towards the US," Mangwana stressed.
"We encourage ongoing discussions with our American counterparts on how subsequent collaboration could be arranged in a way that respects the sovereignty and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the government's concerns, but urged that negotiations should continue since a large portion of the country's HIV programmes were funded by foreign aid.
"In cases where technical issues arise, including those involving information security or agreement terms, these can frequently be addressed through technical clarification and negotiated safeguards," it commented.
The situation emphasises the complex debate between receiving crucial international aid and safeguarding local interests in an ever more data-driven world.